SRS Capital Advisors »

Indivior Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $752 21 35.86

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)

View all positions for SRS Capital Advisors

Top funds holding Indivior Pharmaceuticals

Madison Avenue Partners
Navellier & Associates
AWM Investment Company
Globeflex Capital
Catalyst Funds Management Pty
EverSource Wealth Advisors
SBI Securities
Rothschild Investment
Bare Financial Services
SRS Capital Advisors

View all funds holding Indivior Pharmaceuticals